Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.
What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

Read More

Overview

Feature Articles

Latest Cardiovascular Disease News and Research

Ultra-processed foods linked to higher prostate cancer risk in men

Ultra-processed foods linked to higher prostate cancer risk in men

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Social disadvantage associated with increased mortality risk in women with early natural menopause

Social disadvantage associated with increased mortality risk in women with early natural menopause

Researchers tracked biological aging for decades and found a striking pattern in women

Researchers tracked biological aging for decades and found a striking pattern in women

How well you balance and move may say more about longevity than you think

How well you balance and move may say more about longevity than you think

Stretchable catheter could help identify high-risk arterial plaque

Stretchable catheter could help identify high-risk arterial plaque

Waist size predicts heart disease risk better than body mass index

Waist size predicts heart disease risk better than body mass index

Semaglutide slows blood protein signature linked to future dementia risk

Semaglutide slows blood protein signature linked to future dementia risk

Scientific statement reframes cardiovascular care for older patients with cognitive impairment and frailty

Scientific statement reframes cardiovascular care for older patients with cognitive impairment and frailty

New pathway explains how zombie cells trigger chronic inflammation

New pathway explains how zombie cells trigger chronic inflammation

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes

Metabolic stress triggers long-lasting immune system changes in diabetes patients

Metabolic stress triggers long-lasting immune system changes in diabetes patients

Nicotine gum may make smokeless tobacco withdrawal easier to manage

Nicotine gum may make smokeless tobacco withdrawal easier to manage

Nighttime light linked to conflicting signs of biological aging

Nighttime light linked to conflicting signs of biological aging

New review links obesity with accelerated biological aging mechanisms

New review links obesity with accelerated biological aging mechanisms

AI sleep model reveals health risks missed by standard apnea scores

AI sleep model reveals health risks missed by standard apnea scores

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Global surveys reveal little progress in tobacco risk awareness over two decades

Global surveys reveal little progress in tobacco risk awareness over two decades

Physical activity linked to lower stroke and death risk in adults with atrial fibrillation

Physical activity linked to lower stroke and death risk in adults with atrial fibrillation

NIH funds smartphone platform to improve driving safety for teens

NIH funds smartphone platform to improve driving safety for teens

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.